BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 34265469)

  • 1. Proteomic Landscape of Exosomes Reveals the Functional Contributions of CD151 in Triple-Negative Breast Cancer.
    Li S; Li X; Yang S; Pi H; Li Z; Yao P; Zhang Q; Wang Q; Shen P; Li X; Ji J
    Mol Cell Proteomics; 2021; 20():100121. PubMed ID: 34265469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic profiling and ROC analysis identify CD151 and ELAVL1 as potential therapy response markers for the antiviral drug in resistant TNBC.
    Marni R; Malla M; Chakraborty A; Malla R
    Life Sci; 2023 May; 320():121534. PubMed ID: 36889667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Marine natural compound cyclo(L-leucyl-L-prolyl) peptide inhibits migration of triple negative breast cancer cells by disrupting interaction of CD151 and EGFR signaling.
    Kgk D; Kumari S; G S; Malla RR
    Chem Biol Interact; 2020 Jan; 315():108872. PubMed ID: 31669320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulation of serum exosomal SUMO1P3 predicts unfavorable prognosis in triple negative breast cancer.
    Na-Er A; Xu YY; Liu YH; Gan YJ
    Eur Rev Med Pharmacol Sci; 2021 Jan; 25(1):154-160. PubMed ID: 33506903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD151 enrichment in exosomes of luminal androgen receptor breast cancer cell line contributes to cell invasion.
    Li D; Lai W; Wang Q; Xiang Z; Nan X; Yang X; Fang Q
    Biochimie; 2021 Oct; 189():65-75. PubMed ID: 34157361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exosomal annexin A6 induces gemcitabine resistance by inhibiting ubiquitination and degradation of EGFR in triple-negative breast cancer.
    Li T; Tao Z; Zhu Y; Liu X; Wang L; Du Y; Cao J; Wang B; Zhang J; Hu X
    Cell Death Dis; 2021 Jul; 12(7):684. PubMed ID: 34238922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA HAND2-AS1 suppressed the growth of triple negative breast cancer via reducing secretion of MSCs derived exosomal miR-106a-5p.
    Xing L; Tang X; Wu K; Huang X; Yi Y; Huan J
    Aging (Albany NY); 2020 Dec; 13(1):424-436. PubMed ID: 33290256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomic investigation on bio-corona of Au, Ag and Fe nanoparticles for the discovery of triple negative breast cancer serum protein biomarkers.
    Del Pilar Chantada-Vázquez M; López AC; Vence MG; Vázquez-Estévez S; Acea-Nebril B; Calatayud DG; Jardiel T; Bravo SB; Núñez C
    J Proteomics; 2020 Feb; 212():103581. PubMed ID: 31731051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteome profiling of triple negative breast cancer cells overexpressing NOD1 and NOD2 receptors unveils molecular signatures of malignant cell proliferation.
    Velloso FJ; Campos AR; Sogayar MC; Correa RG
    BMC Genomics; 2019 Feb; 20(1):152. PubMed ID: 30791886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum exosomal-annexin A2 is associated with African-American triple-negative breast cancer and promotes angiogenesis.
    Chaudhary P; Gibbs LD; Maji S; Lewis CM; Suzuki S; Vishwanatha JK
    Breast Cancer Res; 2020 Jan; 22(1):11. PubMed ID: 31992335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative proteomic profiling of triple-negative breast cancer reveals that up-regulation of RhoGDI-2 is associated to the inhibition of caspase 3 and caspase 9.
    Muñiz Lino MA; Palacios-Rodríguez Y; Rodríguez-Cuevas S; Bautista-Piña V; Marchat LA; Ruíz-García E; Astudillo-de la Vega H; González-Santiago AE; Flores-Pérez A; Díaz-Chávez J; Carlos-Reyes Á; Álvarez-Sánchez E; López-Camarillo C
    J Proteomics; 2014 Dec; 111():198-211. PubMed ID: 24768906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating the influence of Human Umbilical Cord Mesenchymal Stem Cells-derived exosomes loaded with miR-3182 on metastatic performance of Triple Negative Breast Cancer cells.
    Khazaei-Poul Y; Shojaei S; Koochaki A; Ghanbarian H; Mohammadi-Yeganeh S
    Life Sci; 2021 Dec; 286():120015. PubMed ID: 34614416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RAB5A in triple-negative breast cancer: a critical role in macrophage reshaping in an exosomal miR-21-dependent manner.
    Qiao L; Dong C; Jia W; Sun G
    Endocr Relat Cancer; 2024 May; 31(5):. PubMed ID: 38470169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adipocyte-derived exosomes promote the progression of triple-negative breast cancer through circCRIM1-dependent OGA activation.
    Li Y; Jiang B; Zeng L; Tang Y; Qi X; Wan Z; Feng W; Xie L; He R; Zhu H; Wu Y
    Environ Res; 2023 Dec; 239(Pt 1):117266. PubMed ID: 37775001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surfaceome profiling enables isolation of cancer-specific exosomal cargo in liquid biopsies from pancreatic cancer patients.
    Castillo J; Bernard V; San Lucas FA; Allenson K; Capello M; Kim DU; Gascoyne P; Mulu FC; Stephens BM; Huang J; Wang H; Momin AA; Jacamo RO; Katz M; Wolff R; Javle M; Varadhachary G; Wistuba II; Hanash S; Maitra A; Alvarez H
    Ann Oncol; 2018 Jan; 29(1):223-229. PubMed ID: 29045505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative proteomic landscape of metaplastic breast carcinoma pathological subtypes and their relationship to triple-negative tumors.
    Djomehri SI; Gonzalez ME; da Veiga Leprevost F; Tekula SR; Chang HY; White MJ; Cimino-Mathews A; Burman B; Basrur V; Argani P; Nesvizhskii AI; Kleer CG
    Nat Commun; 2020 Apr; 11(1):1723. PubMed ID: 32265444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific microRNA signatures in exosomes of triple-negative and HER2-positive breast cancer patients undergoing neoadjuvant therapy within the GeparSixto trial.
    Stevic I; Müller V; Weber K; Fasching PA; Karn T; Marmé F; Schem C; Stickeler E; Denkert C; van Mackelenbergh M; Salat C; Schneeweiss A; Pantel K; Loibl S; Untch M; Schwarzenbach H
    BMC Med; 2018 Oct; 16(1):179. PubMed ID: 30301470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exosomal GPT2 derived from triple-negative breast cancer cells promotes metastasis by activating BTRC.
    Cui M; Peng J; Zhou Y; Wang X; Cui D
    Thorac Cancer; 2023 Jul; 14(21):2018-2025. PubMed ID: 37287397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrin-associated CD151 drives ErbB2-evoked mammary tumor onset and metastasis.
    Deng X; Li Q; Hoff J; Novak M; Yang H; Jin H; Erfani SF; Sharma C; Zhou P; Rabinovitz I; Sonnenberg A; Yi Y; Zhou P; Stipp CS; Kaetzel DM; Hemler ME; Yang XH
    Neoplasia; 2012 Aug; 14(8):678-89. PubMed ID: 22952421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Profiling of the tetraspanin CD151 web and conspiracy of CD151/integrin β1 complex in the progression of hepatocellular carcinoma.
    Devbhandari RP; Shi GM; Ke AW; Wu FZ; Huang XY; Wang XY; Shi YH; Ding ZB; Xu Y; Dai Z; Fan J; Zhou J
    PLoS One; 2011; 6(9):e24901. PubMed ID: 21961047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.